Henry Ford Health System Chief Academic Officer and neurosurgeon Dr. Steven Kalkanis discusses the new Henry Ford study that found hydroxychloroquine lowered the mortality rate in hospitalized COVID-19 patients when treated early.
Henry Ford Health System Chief Academic Officer and neurosurgeon Dr. Steven Kalkanis discusses the new Henry Ford study that found hydroxychloroquine lowered the mortality rate in hospitalized COVID-19 patients when treated early.
#COVID19 #NTVKenya #Coronavirus Subscribe to NTV Kenya channel for latest Kenyan news today and everyday. Get the Kenya news updates, discussions and other exciting shows. Website: ntv.nation.co.ke || Paper: Daily Nation || Twitter: @ntvkenya || Facebook: NTV Kenya || Instagram:…
The number of people to die with Covid-19 worldwide passes half a million Since the outbreak began, there have been more than 10 million cases With cases rising in 30 US states, the Texas governor speaks of “swift and dangerous…